Drug Shortage Report for NAT-MONTELUKAST

Last updated on 2025-01-02 History
Report ID 226582
Drug Identification Number 02522128
Brand name NAT-MONTELUKAST
Common or Proper name Montelukast
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30 UD BLS
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-04-29
Actual start date 2024-04-30
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-01-02
Company comments Long Term Back Order
Health Canada comments
Tier 3 Status No
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-01-02 French Compare
v8 2025-01-02 English Compare
v7 2024-12-16 French Compare
v6 2024-12-16 English Compare
v5 2024-07-05 French Compare
v4 2024-07-05 English Compare
v3 2024-04-30 English Compare
v2 2024-04-29 French Compare
v1 2024-04-29 English Compare

Showing 1 to 9 of 9